Merck Closing 16 Sites, Including Two in United States
"Today's announcement is another important step as we successfully integrate our global operations on schedule and move forward with Merck's strategic priorities," said Richard T. Clark, chairman and CEO of Merck. "These changes are crucial to drive future growth and realize the promise of being a global healthcare leader for the long term. While we believe these actions are necessary to support Merck's competitive advantage, they required difficult decisions that will impact some of our colleagues, their families and local communities. We will implement our restructuring plans with the utmost care and respect for the hard-working and talented employees of Merck."
Merck expects that the consolidation will save the company $2.7 billion to $3.1 billion in 2012, just shy of its $3.5 billion cost-savings goal.
The company is closing research sites in Montreal and Cambridge, Massachusetts, along with others around the world. It will also shutter manufacturing plants in Miami Lakes, Florida, plus seven other global sites.
A Site Selector’s Checklist for Locating in the U.S.
Location USA 2019
Where to Invest in the Booming Aerospace Manufacturing Industry
2019 Auto/Aero Site Guide
A Changing Food Manufacturing Industry
2017 Food Processing
What Should High-Growth Companies Look for in a Community?
Front Line: Trend Toward Microfactories Continues
33rd Annual Corporate Survey & the 15th Annual Consultants Survey